| Date Filed | Type | Description |
| 08/09/2023 |
4
| Wettig Thane (Chief Commercial Officer) has filed a Form 4 on FIBROGEN INC|
Txns:
| Granted 200,000 shares
@ $0
Granted 300,000 options to buy
@ $1.77, valued at
$531k
|
|
| 06/09/2023 |
4
| Wettig Thane (Chief Commercial Officer) has filed a Form 4 on FIBROGEN INC|
Txns:
| Sold 472 shares
@ $17.0356, valued at
$8k
Sold 1,286 shares
@ $17.0377, valued at
$21.9k
|
|
| 06/07/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/24/2023 |
4
| Wettig Thane (Chief Commercial Officer) has filed a Form 4 on FIBROGEN INC|
Txns:
| Sold 905 shares
@ $18.71, valued at
$16.9k
|
|
| 03/10/2023 |
4
| Wettig Thane (Chief Commercial Officer) has filed a Form 4 on FIBROGEN INC|
Txns:
| Sold 6,265 shares
@ $21.1559, valued at
$132.5k
Granted 5,799 shares
@ $0
Granted 9,338 shares
@ $0
Sold 2,938 shares
@ $20.1973, valued at
$59.3k
Sold 4,731 shares
@ $20.1973, valued at
$95.6k
|
|
| 02/23/2023 |
4
| Wettig Thane (Chief Commercial Officer) has filed a Form 4 on FIBROGEN INC|
Txns:
| Granted 25,000 shares
@ $0
Granted 42,000 options to buy
@ $22.6, valued at
$949.2k
|
|
| 02/02/2023 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 12/28/2022 |
4
| Wettig Thane (Chief Commercial Officer) has filed a Form 4 on FIBROGEN INC|
Txns:
| Sold 734 shares
@ $15.8, valued at
$11.6k
|
|
| 12/09/2022 |
4
| Wettig Thane (Chief Commercial Officer) has filed a Form 4 on FIBROGEN INC|
Txns:
| Sold 382 shares
@ $15.79, valued at
$6k
|
|
| 09/26/2022 |
4
| Wettig Thane (Chief Commercial Officer) has filed a Form 4 on FIBROGEN INC|
Txns:
| Paid exercise price by delivering 655 shares
@ $12.26, valued at
$8k
|
|
| 09/08/2022 |
4
| Wettig Thane (Chief Commercial Officer) has filed a Form 4 on FIBROGEN INC|
Txns:
| Paid exercise price by delivering 360 shares
@ $12.26, valued at
$4.4k
|
|
| 06/24/2022 |
4
| Wettig Thane (Chief Commercial Officer) has filed a Form 4 on FIBROGEN INC|
Txns:
| Paid exercise price by delivering 655 shares
@ $11.42, valued at
$7.5k
|
|
| 06/08/2022 |
4
| Wettig Thane (Chief Commercial Officer) has filed a Form 4 on FIBROGEN INC|
Txns:
| Paid exercise price by delivering 360 shares
@ $9.5, valued at
$3.4k
|
|
| 03/24/2022 |
4
| Wettig Thane (Chief Commercial Officer) has filed a Form 4 on FIBROGEN INC|
Txns:
| Paid exercise price by delivering 655 shares
@ $13.31, valued at
$8.7k
|
|
| 03/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2022 |
4
| Wettig Thane (Chief Commercial Officer) has filed a Form 4 on FIBROGEN INC|
Txns:
| Granted 45,000 shares
@ $0
Granted 75,000 options to buy
@ $15.6, valued at
$1.2M
|
|
| 12/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/24/2021 |
4
| Wettig Thane (Chief Commercial Officer) has filed a Form 4 on FIBROGEN INC|
Txns:
| Paid exercise price by delivering 620 shares
@ $10.18, valued at
$6.3k
|
|
| 08/30/2021 |
4
| Wettig Thane (Chief Commercial Officer) has filed a Form 4 on FIBROGEN INC|
Txns:
| Bought 3,100 shares
@ $11.53, valued at
$35.7k
|
|
| 06/24/2021 |
4
| Wettig Thane (Chief Commercial Officer) has filed a Form 4 on FIBROGEN INC|
Txns:
| Paid exercise price by delivering 2,593 shares
@ $27.65, valued at
$71.7k
|
|
| 02/26/2021 |
4
| Wettig Thane (Chief Commercial Officer) has filed a Form 4 on FIBROGEN INC|
Txns:
| Granted 16,500 shares
@ $0
Granted 32,100 options to buy
@ $53.01, valued at
$1.7M
|
|
| 02/26/2021 |
3/A
| Wettig Thane (Chief Commercial Officer) has filed a Form 3/A on FIBROGEN INC |
| 06/24/2020 |
4
| Wettig Thane (Chief Commercial Officer) has filed a Form 4 on FIBROGEN INC|
Txns:
| Granted 30,000 shares
@ $0
Granted 90,000 options to buy
@ $42.08, valued at
$3.8M
|
|
| 06/24/2020 |
3
| Wettig Thane (Chief Commercial Officer) has filed a Form 3 on FIBROGEN INC |